Technology and consulting giant IBM (NYSE:IBM) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 12.1% year on year to $19.69 billion. Its non-GAAP profit of $4.52 per share was 5.4% above analysts’ consensus estimates.
Is now the time to buy IBM? Find out in our full research report (it’s free for active Edge members).
IBM (IBM) Q4 CY2025 Highlights:
- Revenue: $19.69 billion vs analyst estimates of $19.21 billion (12.1% year-on-year growth, 2.5% beat)
- Adjusted EPS: $4.52 vs analyst estimates of $4.29 (5.4% beat)
- Adjusted EBITDA: $6.45 billion vs analyst estimates of $6.19 billion (32.7% margin, 4.2% beat)
- Operating Margin: 23.1%, in line with the same quarter last year
- Market Capitalization: $275 billion
StockStory’s Take
IBM’s Q4 performance was marked by growth in software and infrastructure, which drove the company to surpass Wall Street’s revenue and profit expectations. Management credited the momentum to strong demand for AI- and automation-centric solutions, as well as continued adoption of its Z17 mainframe platform. CEO Arvind Krishna noted that “software grew 9%, our highest annual growth rate in history,” highlighting the impact of IBM’s focus on hybrid cloud and AI. Consulting services also contributed modestly, with clients increasingly seeking help to integrate AI at scale.
Looking ahead, IBM’s management expects momentum in software, generative AI, and strategic acquisitions to continue shaping the company’s trajectory. Krishna emphasized that the “opportunity is to make it easy for clients to build AI that is specific to their data, their processes, and their competitive needs,” pointing to the integration of new platforms like Confluent and ongoing innovation as key catalysts. CFO Jim Kavanaugh added that the company’s durable free cash flow generation would support ongoing investment in innovation and margin expansion, while acknowledging potential headwinds related to acquisition dilution and product cycle dynamics.
Key Insights from Management’s Remarks
IBM’s Q4 performance was shaped by surging demand for AI-driven solutions, mainframe momentum, and successful integration of key acquisitions, offset by a slight decline in operating margin.
- Accelerated AI adoption: Management highlighted rapid growth in generative AI, with the GenAI book of business exceeding $12.5 billion and both software and consulting segments seeing their largest quarterly increases to date. Enterprise clients are adopting IBM’s AI platforms to streamline operations and drive efficiency.
- Mainframe resurgence: The Z17 mainframe launch was a standout, with revenue up 61% year over year for the quarter and marking the strongest start for a mainframe cycle in over two decades. Clients valued Z17’s real-time AI inferencing and quantum-safe security features.
- Software-led transformation: IBM continued its pivot to a software-led business, with software now accounting for 45% of total revenue, up from 25% in 2018. Three out of four software sub-segments posted double-digit growth, especially in data and automation.
- M&A synergy realization: Recent acquisitions, including HashiCorp and the announced Confluent deal, played a significant role in expanding IBM’s hybrid cloud and automation capabilities. Management cited early signs of revenue and operational synergies, with HashiCorp delivering adjusted EBITDA accretion ahead of expectations.
- Productivity and cost discipline: IBM achieved $4.5 billion in annual run-rate productivity savings, enabling continued investment in R&D and strategic acquisitions while supporting margin expansion, despite a year-on-year decline in operating margin attributed to workforce rebalancing and integration costs.
Drivers of Future Performance
IBM’s outlook is underpinned by ongoing demand for AI and hybrid cloud, continued software growth, and integration of acquisitions, while facing margin headwinds from product cycles and M&A dilution.
- Sustained software momentum: Management expects software to grow 10% in the coming year, led by organic innovation in AI and automation, a robust recurring revenue base, and further M&A contributions from Confluent. Recurring revenue and demand for Red Hat’s OpenShift and data products are anticipated to drive this acceleration.
- Consulting and AI transformation: The consulting business is forecast to see low- to mid-single-digit revenue growth, supported by a strong backlog in AI projects and expanded client engagements. Management expects generative AI to represent a growing share of consulting revenue as enterprises invest in digital transformation initiatives.
- Margin pressures and dilution risks: IBM anticipates about a one-point expansion in operating pretax margin, driven by software mix and productivity gains, but notes headwinds from mainframe product cycles and acquisition-related dilution. The closing of the Confluent deal is expected to be dilutive in the short term but accretive to adjusted EBITDA within the first year post-close.
Catalysts in Upcoming Quarters
Going forward, the StockStory team will closely watch (1) the pace of integration and synergy realization from the Confluent acquisition, (2) ongoing adoption rates and monetization of IBM’s AI and automation platforms, and (3) the conversion of consulting backlog into revenue, especially for AI-related projects. Execution on margin expansion and effective management of acquisition-related dilution will also be important markers of progress.
IBM currently trades at $316.72, up from $294.21 just before the earnings. Is there an opportunity in the stock?See for yourself in our full research report (it’s free).
Our Favorite Stocks Right Now
If your portfolio success hinges on just 4 stocks, your wealth is built on fragile ground. You have a small window to secure high-quality assets before the market widens and these prices disappear.
Don’t wait for the next volatility shock. Check out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.